Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coping with somatic comorbidities: striving for complete recovery.

Christer Allgulander1, Siegfried Kasper

  • 1Karolinska Institute, Neurotec Department, Huddinge University Hospital, Stockholm. Christer.Allgulander@neurotec.ki.se

Psychopharmacology Bulletin
|December 20, 2002
PubMed
Summary

Antidepressants effectively treat chronic pain and fatigue in patients with medical conditions. These medications, including TCAs and SSRIs, show promise beyond depression, aiding conditions like diabetic neuropathy and fibromyalgia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2022
Same author

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part II: OCD and PTSD.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2022
Same author

Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression.

Molecular psychiatry·2019
Same author

Efficacy of venlafaxine extended release in major depressive disorder patients: effect of baseline anxiety symptom severity.

International clinical psychopharmacology·2019
Same author

Editorial.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2018
Same author

The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives.

The international journal of neuropsychopharmacology·2018

Area of Science:

  • Psychiatry
  • Neurology
  • Pain Management

Background:

  • Depression and anxiety often manifest as somatic complaints, leading to underdiagnosis and undertreatment.
  • Patients with severe medical conditions frequently experience comorbid depression and anxiety.
  • Somatic symptoms like pain, headache, and fatigue can mask underlying psychiatric disorders.

Purpose of the Study:

  • To review the efficacy of antidepressants in treating somatic symptoms associated with chronic medical conditions.
  • To highlight the underrecognition of depression and anxiety in medically ill patients presenting with physical complaints.
  • To explore the expanding therapeutic applications of antidepressants beyond primary mood and anxiety disorders.

Main Methods:

  • Literature review of studies on antidepressant use for non-psychiatric conditions.

Related Experiment Videos

  • Analysis of clinical trial data for Tricyclic Antidepressants (TCAs), Selective Serotonin Reuptake Inhibitors (SSRIs), and Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs).
  • Examination of evidence for treating conditions such as diabetic neuropathy, fibromyalgia, headache, and premenstrual dysphoric disorder.

    • Main Results:

    • TCAs demonstrate efficacy in managing diabetic neuropathy, fibromyalgia, and headaches.
    • SSRIs are effective in alleviating symptoms of premenstrual dysphoric disorder and fibromyalgia.
    • Venlafaxine (an SNRI) shows potential in pilot studies for diabetic neuropathy, fibromyalgia, migraine, premenstrual dysphoric disorder, and stroke.

    Conclusions:

    • Antidepressants possess significant therapeutic potential for managing somatic symptoms in patients with chronic medical conditions.
    • Further controlled studies are warranted to confirm the efficacy of SNRIs like venlafaxine in various pain and neurological conditions.
    • Recognizing and treating comorbid depression and anxiety is crucial for comprehensive patient care in chronic illness.